Target intelligence / Profile preview

Endogenous metabolic and redox pathways

Molecular classification
Other
01

Overview

Endogenous metabolic and redox pathways represent the integrated network of biochemical reactions responsible for energy production, macromolecule synthesis, and the maintenance of cellular reduction-oxidation (redox) balance. These pathways, including glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway, are essential for cellular survival and function (StatPearls, 2023). Redox pathways specifically manage the production and neutralization of reactive oxygen species (ROS) through systems like glutathione and thioredoxin to prevent oxidative damage to DNA, proteins, and lipids (NIH, 2022). Dysregulation of these pathways is central to the pathogenesis of various conditions, such as cancer, where metabolic reprogramming (the Warburg effect) facilitates rapid proliferation, and neurodegenerative diseases, where chronic oxidative stress contributes to neuronal loss (Nature Reviews Cancer, 2011). Because this term describes a broad set of physiological systems rather than a discrete molecular entity like a single enzyme or receptor, it is classified as a therapeutic category or biological process rather than a specific drug target (PubMed, 2020).

Other names
Metabolic pathwaysRedox homeostasisCellular metabolismOxidative stress pathwaysIntermediary metabolism
02

Mechanism of action

Modulation of specific enzymatic activities within metabolic cycles or the enhancement/inhibition of cellular antioxidant defense systems to alter cellular energy state or redox potential.

03

Biological functions

MetabolismRedox signalingEnergy productionCellular homeostasisOxidative stress response
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMetabolic syndromeInflammationDiabetes mellitus
05

Safety considerations

Systemic toxicity due to pathway ubiquityDisruption of essential physiological homeostasisNarrow therapeutic windowPotential for metabolic acidosis or alkalosisOff-target effects on healthy tissue metabolism
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Reactive oxygen species (ROS) levelsGlutathione (GSH/GSSG) ratioLactate levelsNAD+/NADH ratioMalondialdehyde (MDA)8-hydroxy-2-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Endogenous metabolic and redox pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous metabolic and redox pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call